Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marinucci

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Contributions to Nephrology|January 1, 1986
Immunosuppressive therapy in high-risk patientsR Cortesini, G Marinucci, E Renna Molajoni, et al.
Gastroenterology|April 1, 1993
Recurrence of hepatitis D (delta) in liver transplants: histopathological aspectsE David, J Rahier, A Pucci, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1990
Alpha interferon plus thymopentine in treatment of HBV and/or HDV positive patients undergoing liver transplantA Gaeta, C Mancini, A Bachetoni, et al.
Transplantation Proceedings|February 1, 1989
Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantationC Mancini, A Gaeta, G Lorino, et al.
Transplantation Proceedings|February 1, 1987
Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patientsR Cortesini, P Berloco, A Famulari, et al.
Lancet (London, England)|August 29, 1987
Liver transplantation in hepatitis delta virus diseaseM Rizzetto, S Macagno, E Chiaberge, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
The Journal of Urology|March 21, 1998
Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejectionM Lazzeri, M Mora, L C Mulder, et al.
American Journal of Epidemiology|February 1, 1983
Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in ItalyA Smedile, C Lavarini, P Farci, et al.
Transplantation Proceedings|February 1, 1989
Results of liver transplantation for hepatitis delta disease without immunoprophylaxisS Agnes, A W Avolio, S C Magalini, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Contributions to Nephrology|January 1, 1986
Immunosuppressive therapy in high-risk patientsR Cortesini, G Marinucci, E Renna Molajoni, et al.
Gastroenterology|April 1, 1993
Recurrence of hepatitis D (delta) in liver transplants: histopathological aspectsE David, J Rahier, A Pucci, et al.
Journal of Biological Regulators and Homeostatic Agents|April 1, 1990
Alpha interferon plus thymopentine in treatment of HBV and/or HDV positive patients undergoing liver transplantA Gaeta, C Mancini, A Bachetoni, et al.
Transplantation Proceedings|February 1, 1989
Alpha interferon therapy in patients with hepatitis infection undergoing organ transplantationC Mancini, A Gaeta, G Lorino, et al.
Transplantation Proceedings|February 1, 1987
Influence of total lymphoid irradiation plus cyclosporine on kidney graft outcome in high-risk patientsR Cortesini, P Berloco, A Famulari, et al.
Lancet (London, England)|August 29, 1987
Liver transplantation in hepatitis delta virus diseaseM Rizzetto, S Macagno, E Chiaberge, et al.
Transplantation Proceedings|February 1, 1995
Mice transgenic for human CD46 and CD55 are protected from human complement attackL C Mulder, M Mora, E Ciccopiedi, et al.
The Journal of Urology|March 21, 1998
Kidneys derived from mice transgenic for human complement blockers are protected in an in vivo model of hyperacute rejectionM Lazzeri, M Mora, L C Mulder, et al.
American Journal of Epidemiology|February 1, 1983
Epidemiologic patterns of infection with the hepatitis B virus-associated delta agent in ItalyA Smedile, C Lavarini, P Farci, et al.
Transplantation Proceedings|February 1, 1989
Results of liver transplantation for hepatitis delta disease without immunoprophylaxisS Agnes, A W Avolio, S C Magalini, et al.
Pageof 4